IL113245A - 3-De((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha l-ribhexopyranosyl) oxy)-11,12-dideoxy-11,12-(n-heteroarylalkylimi-nocarbonyloxy)-6-o-methyl-3 oxy erythromycin derivatives their preparation process and pharmaceutical compositions containing them - Google Patents

3-De((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha l-ribhexopyranosyl) oxy)-11,12-dideoxy-11,12-(n-heteroarylalkylimi-nocarbonyloxy)-6-o-methyl-3 oxy erythromycin derivatives their preparation process and pharmaceutical compositions containing them

Info

Publication number
IL113245A
IL113245A IL11324595A IL11324595A IL113245A IL 113245 A IL113245 A IL 113245A IL 11324595 A IL11324595 A IL 11324595A IL 11324595 A IL11324595 A IL 11324595A IL 113245 A IL113245 A IL 113245A
Authority
IL
Israel
Prior art keywords
methyl
dideoxy
oxy
ribhexopyranosyl
heteroarylalkylimi
Prior art date
Application number
IL11324595A
Other languages
English (en)
Other versions
IL113245A0 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of IL113245A0 publication Critical patent/IL113245A0/xx
Publication of IL113245A publication Critical patent/IL113245A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL11324595A 1994-05-03 1995-04-04 3-De((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha l-ribhexopyranosyl) oxy)-11,12-dideoxy-11,12-(n-heteroarylalkylimi-nocarbonyloxy)-6-o-methyl-3 oxy erythromycin derivatives their preparation process and pharmaceutical compositions containing them IL113245A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9405368A FR2719587B1 (fr) 1994-05-03 1994-05-03 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
IL113245A0 IL113245A0 (en) 1995-07-31
IL113245A true IL113245A (en) 1999-11-30

Family

ID=9462785

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11324595A IL113245A (en) 1994-05-03 1995-04-04 3-De((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha l-ribhexopyranosyl) oxy)-11,12-dideoxy-11,12-(n-heteroarylalkylimi-nocarbonyloxy)-6-o-methyl-3 oxy erythromycin derivatives their preparation process and pharmaceutical compositions containing them

Country Status (43)

Country Link
US (2) US5635485A (hu)
EP (1) EP0680967B1 (hu)
JP (4) JP2992540B2 (hu)
KR (1) KR100312267B1 (hu)
CN (2) CN1052984C (hu)
AP (1) AP558A (hu)
AT (1) ATE172203T1 (hu)
AU (1) AU684027B2 (hu)
BG (1) BG63087B1 (hu)
BR (1) BR9507700A (hu)
CA (1) CA2189271C (hu)
CZ (1) CZ293455B6 (hu)
DE (2) DE69505296T2 (hu)
DK (1) DK0680967T3 (hu)
DZ (1) DZ1878A1 (hu)
EE (1) EE03263B1 (hu)
ES (1) ES2122472T3 (hu)
FI (1) FI111263B (hu)
FR (1) FR2719587B1 (hu)
GE (1) GEP19991538B (hu)
HK (1) HK1010732A1 (hu)
HU (2) HU219599B (hu)
IL (1) IL113245A (hu)
LU (1) LU90872I2 (hu)
LV (1) LV11739B (hu)
MA (1) MA23534A1 (hu)
MD (1) MD1233C2 (hu)
NL (1) NL300077I1 (hu)
NO (2) NO308853B1 (hu)
NZ (1) NZ285416A (hu)
OA (1) OA10319A (hu)
PL (1) PL182034B1 (hu)
RO (1) RO113350B1 (hu)
RU (1) RU2144036C1 (hu)
SI (1) SI0680967T1 (hu)
SK (1) SK281707B6 (hu)
TJ (1) TJ313B (hu)
TN (1) TNSN95049A1 (hu)
TW (1) TW341573B (hu)
UA (1) UA51618C2 (hu)
WO (1) WO1995029929A1 (hu)
YU (1) YU49235B (hu)
ZA (1) ZA953501B (hu)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2215178A1 (en) * 1995-06-27 1997-01-16 Takeda Chemical Industries, Ltd. 4-acylamino(halogeno) alkyl-quinoline derivatives, their preparation and their use as melatonin agonists
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
CN100441591C (zh) * 1996-09-04 2008-12-10 艾博特公司 酮基内酯类化合物，其用途和制备方法以及药用组合物
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5780605A (en) * 1997-09-08 1998-07-14 Abbott Laboratories 6,9-bridged erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
ES2243066T3 (es) * 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
EP1137654A1 (en) 1998-12-10 2001-10-04 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
SI1147121T1 (en) * 1999-01-27 2004-04-30 Pfizer Products Inc. Ketolide antibiotics
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6451768B1 (en) 1999-04-16 2002-09-17 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6939861B2 (en) * 1999-04-16 2005-09-06 Kosan Biosciences, Inc. Amido macrolides
MXPA01010524A (es) 1999-04-16 2002-03-14 Kosan Biosciences Inc Agentes macrolidos anti-infecciosos.
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6399582B1 (en) 1999-04-16 2002-06-04 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6514944B2 (en) 1999-04-16 2003-02-04 Kosan Biosciences, Inc. Macrolide antiinfective agents
EE200100613A (et) * 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
FR2797875B1 (fr) * 1999-08-26 2001-10-19 Hoechst Marion Roussel Inc Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
KR100502031B1 (ko) * 2000-08-22 2005-07-25 바실리어 파마슈티카 아게 항균 활성을 갖는 신규한 매크롤라이드
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
US8063021B2 (en) * 2002-01-17 2011-11-22 Kosan Biosciences Incorporated Ketolide anti-infective compounds
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
ATE429441T1 (de) 2002-07-08 2009-05-15 Glaxosmithkline Zagreb Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
AU2003255851B2 (en) 2002-07-08 2009-07-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
US6916934B2 (en) * 2003-02-11 2005-07-12 Aventis Pharma Deutschland Gmbh Process for preparing pyridine-substituted amino ketal derivatives
EP2772254A3 (en) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Novel Antibacterial Agents
JP2006524706A (ja) * 2003-04-25 2006-11-02 カイロン コーポレイション 新規なケトライド誘導体
US20050101548A1 (en) * 2003-09-12 2005-05-12 Xiaodong Lin Antimicrobial derivatives
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法
ES2294733T3 (es) * 2004-04-28 2008-04-01 Alembic Limited Proceso para la preparacion de telitromicina.
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
US20090170790A1 (en) * 2004-10-25 2009-07-02 Biswajit Das Ketolide derivatives as antibacterial agents
AP2007004026A0 (en) 2004-12-21 2007-06-30 Pfizer Prod Inc Macrolides
WO2006085507A1 (ja) * 2005-02-08 2006-08-17 Murata Manufacturing Co., Ltd. 表面実装型負特性サーミスタ
FR2882522B1 (fr) 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
WO2006129257A2 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
WO2007049296A2 (en) * 2005-10-28 2007-05-03 Alembic Limited Amorphous form of telithromycin
WO2007059307A2 (en) * 2005-11-15 2007-05-24 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of telithromycin
EP1954294A2 (en) * 2005-11-23 2008-08-13 Ranbaxy Laboratories Limited Use of macrolide derivatives for treating acne
EP1960413A2 (en) * 2005-11-23 2008-08-27 Ranbaxy Laboratories Limited Macrolides derivatives as antibacterial agents
EP1957508A2 (en) * 2005-11-23 2008-08-20 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
US7595300B2 (en) 2005-12-13 2009-09-29 Kosan Biosciences Incorporated 7-quinolyl ketolide antibacterial agents
GB0600238D0 (en) * 2006-01-06 2006-02-15 Sandoz Ag Organic compounds
WO2007091393A1 (ja) * 2006-02-07 2007-08-16 Taisho Pharmaceutical Co., Ltd. １０ａ－アザライド化合物
CA2661538A1 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
WO2008023383A1 (en) * 2006-08-25 2008-02-28 Alembic Limited Novel process for the preparation of telithromycin
ES2306590B1 (es) * 2006-12-15 2009-08-07 Ercros Industrial,S .A. Formas cristalinas i y ii de telitromicina.
EP2177526A4 (en) * 2007-08-06 2012-08-22 Taisho Pharmaceutical Co Ltd 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
CA2699914C (en) 2007-09-20 2013-12-31 Herman Miller, Inc. Load support structure
JP5698979B2 (ja) 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
EP2220104A1 (en) * 2007-10-25 2010-08-25 Sandoz AG Process for the production of telithromycin
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
CN105616437A (zh) * 2008-10-24 2016-06-01 森普拉制药公司 使用含三唑的大环内酯的生物防御
AU2010252641B2 (en) 2009-05-27 2015-09-17 Wockhardt Research Centre Ketolide compounds having antimicrobial activity
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
EP3009442B1 (en) 2010-03-22 2019-06-19 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
DK2673285T3 (en) 2010-12-09 2017-10-16 Wockhardt Ltd Ketolide compounds
AR085286A1 (es) 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
CA2830861C (en) 2011-03-22 2017-01-24 Wockhardt Limited Process for preparation of ketolide compounds
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ，インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
CA2907085A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CN105524132B (zh) * 2014-09-30 2019-07-02 中国医学科学院药物研究所 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用
DE102015201783A1 (de) 2015-02-02 2016-08-04 Friedrich Baur Verfahren zur Herstellung eines Füllstoffs aus Textilfasern sowie Textil mit einem solchen Füllstoff
CN107129514B (zh) * 2016-03-02 2019-12-13 中国医学科学院药物研究所 红霉素a酮内酯类抗生素衍生物、其制备方法及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
US4434174A (en) * 1980-02-11 1984-02-28 Berlex Laboratories, Inc. Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
IE810250L (en) * 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4568687A (en) * 1983-02-28 1986-02-04 American Cyanamid Company N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
US4489089A (en) * 1983-04-06 1984-12-18 American Cyanamid Company Substituted N-[ω-(1H-imidazol-1-yl)alkyl]-amides
ZA84949B (en) * 1983-04-06 1984-09-26 American Cyanamid Co Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides
AU573828B2 (en) * 1984-05-17 1988-06-23 E.R. Squibb & Sons, Inc. Tetrahydronaphthalenols
GB8425104D0 (en) * 1984-10-04 1984-11-07 Ici America Inc Amide derivatives
DE3540376A1 (de) * 1985-11-14 1987-05-21 Bayer Ag Verfahren zur inhibierung der wasserstoffinduzierten korrosion von metallischen werkstoffen
ES2054684T3 (es) * 1986-10-29 1994-08-16 Pfizer Procedimientos para la preparacion de 2-(1-pentil-3-guanidino)-4-(2-metil-4-imidazolil) tiazol y el dihidrocloruro trihidratado cristalino del mismo.
DE3930669A1 (de) * 1989-09-14 1991-03-28 Basf Ag Verfahren zur herstellung von uretdiongruppen aufweisenden polyisocyanaten
JP2899028B2 (ja) * 1989-12-01 1999-06-02 協和醗酵工業株式会社 ジベンゾオキセピン誘導体
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
CA2096969C (en) * 1990-11-28 2000-11-21 Masato Kashimura 6-0-methylerythromycin a derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
TW370529B (en) * 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates

Also Published As

Publication number Publication date
JP2007269810A (ja) 2007-10-18
CA2189271A1 (fr) 1995-11-09
CN1151746A (zh) 1997-06-11
DZ1878A1 (fr) 2002-02-17
FI964395A0 (fi) 1996-10-31
JPH11152296A (ja) 1999-06-08
RO113350B1 (ro) 1998-06-30
CN1088709C (zh) 2002-08-07
JP2992540B2 (ja) 1999-12-20
ATE172203T1 (de) 1998-10-15
NL300077I1 (nl) 2002-03-01
HUT75698A (en) 1997-05-28
NO964654D0 (no) 1996-11-04
TW341573B (en) 1998-10-01
JP2007045847A (ja) 2007-02-22
DE69505296T2 (de) 1999-04-22
HU9904687D0 (en) 2000-03-28
CZ321496A3 (en) 1997-08-13
FI964395A (fi) 1996-10-31
AP558A (en) 1996-11-07
DE10299001I2 (de) 2012-07-05
UA51618C2 (uk) 2002-12-16
AU684027B2 (en) 1997-11-27
CA2189271C (fr) 2005-12-27
YU27095A (sh) 1998-05-15
NO964654L (no) 1996-11-04
BG100951A (en) 1997-08-29
FR2719587B1 (fr) 1996-07-12
YU49235B (sh) 2004-12-31
PL182034B1 (pl) 2001-10-31
KR100312267B1 (ko) 2002-06-22
ES2122472T3 (es) 1998-12-16
IL113245A0 (en) 1995-07-31
NO2001027I1 (no) 2002-01-28
LV11739A (lv) 1997-04-20
MX9605208A (es) 1997-09-30
US6100404A (en) 2000-08-08
EP0680967B1 (fr) 1998-10-14
EE03263B1 (et) 2000-04-17
MD1233B1 (en) 1999-05-31
MA23534A1 (fr) 1995-12-31
RU2144036C1 (ru) 2000-01-10
NZ285416A (en) 1997-07-27
GEP19991538B (en) 1999-03-05
DK0680967T3 (da) 1999-06-23
BR9507700A (pt) 1997-08-19
AP9500744A0 (en) 1995-07-31
CN1229082A (zh) 1999-09-22
JPH0853489A (ja) 1996-02-27
SK140296A3 (en) 1998-04-08
WO1995029929A1 (fr) 1995-11-09
JP4750755B2 (ja) 2011-08-17
US5635485A (en) 1997-06-03
MD1233C2 (ro) 2000-10-31
AU2449995A (en) 1995-11-29
NO308853B1 (no) 2000-11-06
CZ293455B6 (cs) 2004-05-12
EP0680967A1 (fr) 1995-11-08
OA10319A (fr) 1997-10-07
FR2719587A1 (fr) 1995-11-10
HU227493B1 (en) 2011-07-28
HU9603038D0 (en) 1997-01-28
PL317071A1 (en) 1997-03-03
DE69505296D1 (de) 1998-11-19
HK1010732A1 (en) 1999-06-25
TNSN95049A1 (fr) 1996-02-06
BG63087B1 (bg) 2001-03-30
LU90872I2 (fr) 2002-03-12
LV11739B (en) 1997-08-20
SK281707B6 (sk) 2001-07-10
CN1052984C (zh) 2000-05-31
DE10299001I1 (de) 2012-07-05
FI111263B (fi) 2003-06-30
JP4658902B2 (ja) 2011-03-23
HU219599B (hu) 2001-05-28
TJ313B (en) 2001-08-06
JP3998828B2 (ja) 2007-10-31
ZA953501B (en) 1996-05-02
SI0680967T1 (en) 1999-02-28

Similar Documents

Publication Publication Date Title
IL113245A (en) 3-De((2,6-dideoxy-3-c-methyl-3-o-methyl-alpha l-ribhexopyranosyl) oxy)-11,12-dideoxy-11,12-(n-heteroarylalkylimi-nocarbonyloxy)-6-o-methyl-3 oxy erythromycin derivatives their preparation process and pharmaceutical compositions containing them
IL112954A (en) 11,12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methylalpha-L-ribohexapyranosyl)oxy)-6-O-methyl-3-oxo-12,11-(oxycarbonyl hydrazono)-erythromycin derivatives their preparation process and their use as medicaments
IL87290A0 (en) Epipodophyllotoxin glucoside 4'-phosphate derivatives,their preparation and pharmaceutical compositions containing them
HUP0002252A3 (en) 9-oxime erythromycin derivatives, process for preparing them and pharmaceutical compositions containing them
IL93914A0 (en) 4(3h)-pteridinones,their preparation and pharmaceutical compositions containing them
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
IL98864A0 (en) Oxazolyl derivatives,process for their preparation and pharmaceutical compositions containing them
IL114059A0 (en) Phenethanolamine derivatives pharmaceutical compositions containing them process for their preparation and their use
IL141956A0 (en) Benzothiazolone derivatives, process for their preparation and pharmaceutical compositions containing them
IL105215A0 (en) 9-fluoro-7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and their esters,their preparation and pharmaceutical compositions containing them
HUP9601062A2 (en) Chromone derivatives, pharmaceutical compositions containing them and process for their preparation
IL105214A0 (en) 7-oxo-7h-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acids and their esters,their preparation and pharmaceutical compositions containing them
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them
IL84146A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
IL86888A0 (en) 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives and pharmaceutical compositions containing them
IL82820A0 (en) Anthracycline glycosides,their preparation and pharmaceutical compositions containing them
HUP9900079A3 (en) 12h-dibenzo[d,g][1,3]dioxocine derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
IL93676A0 (en) Anthracycline derivatives,their preparation and pharmaceutical compositions containing them
ZA898179B (en) Tylosin derivatives,process for the preparation thereof and pharmaceutical compositions containing them
HUP9600061A2 (en) 3-alkoxycarbonyl-1,3,4-thiadiazin-2-on derivatives, process for their preparation and pharmaceutical compositions containing the same
IL111797A0 (en) Thionophosphate derivatives, process for their preparation and pharmaceutical compositions containing them
IL113649A0 (en) 8-amino-pyrido [1,2,3-d, e] [1,3,4] benzoxadiazine derivatives their preparation and pharmaceutical compositions containing them
SG33434A1 (en) Pharmaceutical preparation containing estra-1,3,5(10)-triene-derivatives
HRP950092B1 (en) Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them
IL113108A0 (en) Anthracycline disaccharides, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
HCE Change of name and address of proprietor(s)
KB Patent renewed
KB Patent renewed
HCA Change of name of proprietor(s) after amalgamation
EXTP Application for extension order is pending
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired